Toby Howell

Toby, what do you think of these new tax laws?

TurboTax experts for business can match you with a tax expert with expertise and knowledge for your specific industry.

To ensure you have confidence, you're maximizing deductions and your taxes are filed correctly.

Yeah, we've already had the injectable battles.

Now we're having the pill battles.

A lot of people say that the convenience factor is probably the tipping point for a lot of people, but also price is a big deal.

At this point, most of the pills work.

You're going to lose weight on any of these GLP-1 class of drugs, whether it's 12% of your weight, whether it's 16% of your weight.

The efficacy is not probably going to be the thing that tilts you one way or the other.

It is going to be like, hey, can I just take this pill with my normal food?

Do I have to not drink for the first 30 minutes of the day?

Also, is it cheaper than the other thing?

So we are seeing a...

Knock on, drag out war now that every pill kind of does the job that you want it to.

And people are saying Foundeo has an edge in that ease of use.

They have an edge maybe on the pricing front as well.

So it could be an absolute monster.

I also think it's less prone to shortages, too.

Given that it is a pill, not an injectable, that reduces all the supply chain complexities around trying to source plastic, trying to source cold storage, like the shots had to be saved at a certain temperature.

When we talk about mass appeal, a pill is obviously easier than an injectable, especially because some people don't really like needles that much, speaking from my own experience here.